Andreas Meliniotis, director of Device Development at Vectura explains how connected devices are helping patients better manage their medications and improve adherence.
European Pharmaceutical Manufacturer sits down with Derek Wang, CEO of data analytics company Stratifyd, to discuss the Covid-19 pandemic and how technology can be better used to predict and potentially curtail disease outbreaks.
EPM speaks to Kevin Deane, vice president of Front-End Innovation and Connected Health at. Phillips-Medisize about the promise of connected health in drug delivery for patients, pharmaceutical providers, and the healthcare industry.
Life sciences firms owe it to themselves to capitalise on new global insights contained within the substantial new regulatory database systems they have had to build for compliance purposes, says Amplexor's David Gwyn.
Dr Campbell Rogers, chief medical officer at HeartFlow discusses how digital technologies can play a role in helping health services identify and treat coronary heart disease.
Daniel Streetman from Wolters Kluwer discusses the potential for pharmacogenomics to transform prescribed drugs and reduce instances of adverse drug reactions.
